Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-24.19	1692.75	-2232.81
Graham Fair Price	-49.41	0.89	1.75
PEG	527.13	1.40	0.22
Price/Book	-3.14	0.76	0.78
Price/Cash Flow	498.39	-90.50	15.12
Prices/Earnings	-275.70	-104.23	-27.74
Price/Sales	-28.27	26.60	37.09
Price/FCF	498.39	-90.50	15.12
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	17.71	0.28	0.23
Operating Margin	60.90	-0.17	-0.45
ROA	75.27	< 0.005	< 0.005
ROE	< 0.005	< 0.005	74.22
ROIC	< 0.005	< 0.005	66.13
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.32	0.04	619.20
Dividends QOQ	3.99	-0.79	-80.12
EBIT QOQ	-1.25	0.47	-62.01
EPS QOQ	-1.24	0.74	-40.09
FCF QOQ	1.25	-1.16	-7.02
Revenue QOQ	-0.93	0.34	-62.89
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	5846.84	4531.48	-22.50
Days Sales Outstanding (DSO)	357.42	266.67	-25.39
Inventory Turnover	0.02	0.02	29.03
Debt/Capitalization	0.25	0.30	22.53
Quick Ratio	0.43	0.59	37.34
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	4.41	5.07	15.11
Cash	1.08	1.47	35.53
Capex	-0.01	0.03	227.29
Free Cash Flow	0.23	-0.04	-83.87
Revenue	0.09	0.12	34.55
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.87	1.90	1.42
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-298.42	266.41	-10.73
Naive Interpretation	Member

06 - Financial Health · Weak

Rating